Literature DB >> 14578883

Mechanism of CD1d-restricted natural killer T cell activation during microbial infection.

Manfred Brigl1, Lynn Bry, Sally C Kent, Jenny E Gumperz, Michael B Brenner.   

Abstract

CD1d-restricted natural killer T (NKT) cells are important for host defense against a variety of microbial pathogens. How and when these T cells become activated physiologically during infection remains unknown. Our data support a model in which NKT cells use a unique activation mechanism not requiring their recognition of microbial antigens. Instead, weak responses to CD1d-presented self antigens were amplified by interleukin 12 made by dendritic cells in response to microbial products, resulting in potent interferon-gamma secretion. NKT cells were among the first lymphocytes to respond during Salmonella typhimurium infection, and their activation in vivo also depended on interleukin 12 and CD1d recognition. We propose this mechanism of activation as a major pathway responsible for the rapid activation of NKT cells in different microbial infections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578883     DOI: 10.1038/ni1002

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  284 in total

1.  Development of spontaneous anergy in invariant natural killer T cells in a mouse model of dyslipidemia.

Authors:  Nicole A Braun; Yanice V Mendez-Fernandez; Roman Covarrubias; Steven A Porcelli; Paul B Savage; Hideo Yagita; Luc Van Kaer; Amy S Major
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-06-10       Impact factor: 8.311

2.  Slam haplotypes modulate the response to lipopolysaccharide in vivo through control of NKT cell number and function.

Authors:  Idil Aktan; Alan Chant; Zachary D Borg; David E Damby; Paige C Leenstra; Graham W J Lilley; Graham W G Lilley; Joseph Petty; Benjamin T Suratt; Cory Teuscher; Edward K Wakeland; Matthew E Poynter; Jonathan E Boyson
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

Review 3.  Going both ways: immune regulation via CD1d-dependent NKT cells.

Authors:  Dale I Godfrey; Mitchell Kronenberg
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

Review 4.  Immunology in the Clinic Review Series; focus on host responses: invariant natural killer T cell activation following transplantation.

Authors:  J-P Jukes; N D Jones
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

5.  Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.

Authors:  Christophe Paget; Stoyan Ivanov; Josette Fontaine; Joelle Renneson; Fany Blanc; Muriel Pichavant; Laure Dumoutier; Bernhard Ryffel; Jean Christophe Renauld; Philippe Gosset; Pierre Gosset; Mustapha Si-Tahar; Christelle Faveeuw; François Trottein
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

Review 6.  Selection of self-reactive T cells in the thymus.

Authors:  Gretta L Stritesky; Stephen C Jameson; Kristin A Hogquist
Journal:  Annu Rev Immunol       Date:  2011-12-05       Impact factor: 28.527

Review 7.  Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.

Authors:  Victoria Lawson
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

Review 8.  Natural Killer T cell obsession with self-antigens.

Authors:  Laurent Gapin; Dale I Godfrey; Jamie Rossjohn
Journal:  Curr Opin Immunol       Date:  2013-02-04       Impact factor: 7.486

Review 9.  NKT cell immune responses to viral infection.

Authors:  Marlowe S Tessmer; Ayesha Fatima; Christophe Paget; Francois Trottein; Laurent Brossay
Journal:  Expert Opin Ther Targets       Date:  2009-02       Impact factor: 6.902

Review 10.  Commensal microbiota and NKT cells in the control of inflammatory diseases at mucosal surfaces.

Authors:  Sebastian Zeissig; Richard S Blumberg
Journal:  Curr Opin Immunol       Date:  2013-11-05       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.